Cannabidiol (CBD) is one of the most abundant components of the cannabis plant and its popularity has been increasing in recent years, as research and legislation have begun to focus on the substance's potential therapeutic benefits. CBD is thought to have neuroprotective effects due to the way it interacts with the CB2 receptors in the brain. It acts on these receptors by creating an anti-inflammatory response in the brain's immune cells, reducing the amount of damage caused by inflammation. Studies have also shown that CBD can inhibit the production of amyloid b and tau, which are characteristics of Alzheimer's disease, and this ability may be related to its anti-inflammatory characteristics.
Additionally, CBD can help combat some of the inflammation caused by a stroke and lead to better outcomes for stroke victims. CBD also appears to work by balancing the dysfunction of the endocannabinoid system in people with depression. It reduces the number of inflammatory molecules, such as chemokines and cytokines, that are present at sites of inflammation. Research has shown that CBD can protect against vascular damage induced by inflammation, which can protect the heart.
Furthermore, CBD has been studied for its potential effects on brain diseases and its ability to relieve pain due to its anti-inflammatory properties. Because CBD lacks intoxication capacity and because CBD tolerance develops at a low rate, it is increasingly considered to be an advantageous substance for therapeutic use. The FDA has even approved an oral drug with CBD, Epidiolex, for use in treating certain types of epilepsy. With all these potential benefits, it is no wonder why CBD oil is becoming increasingly popular for its potential effects on the brain.